search for




 

What is the pancreatic duct size limit for a safe duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy? A retrospective study
Ann Hepatobiliary Pancreat Surg
Published online December 14, 2021;  https://doi.org/10.14701/ahbps.21-054
Copyright © 2021 The Korean Association of Hepato-Biliary-Pancreatic Surgery.

Kit-Fai Lee, Kandy Kam Cheung Wong, Eugene Yee Juen Lo, Janet Wui Cheung Kung, Hon-Ting Lok, Charing Ching Ning Chong, John Wong, Paul Bo San Lai, Kelvin Kwok Chai Ng

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China
Correspondence to: Kit-Fai Lee
Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, 30-32, Ngan Shing Street, Shatin, N.T., Hong Kong SAR, China
Tel: +852-35051496, Fax: +852-26377974, E-mail: leekf@surgery.cuhk.edu.hk
ORCID: https://orcid.org/0000-0003-0637-0291
Received April 16, 2021; Revised August 12, 2021; Accepted September 6, 2021.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Abstract
Backgrounds/Aims: Postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD) remains a dreadful complication. Duct-to-mucosa pancreaticojejunostomy (DTMPJ) is a commonly performed anastomosis after PD. This study aims to evaluate whether there is a size limit of pancreatic duct below which POPF rate increases significantly after DTMPJ.
Methods: A retrospective study was performed from a database with prospectively collected data on consecutive patients undergoing DTMPJ.
Results: Between the years 2003 and 2019, a total of 288 patients with DTMPJ were recruited. POPF occurred in 56.3% of the patients, of which 43.8% were biochemical leak, 8.7% were grade B, and 1.4% were grade C. Overall operative morbidity was 51.4%, of which 19.1% were major complications. Five patients (1.7%) died within 90 days of operation. Patients with grade B/C POPF had significantly soft pancreas (p < 0.001), smaller duct size (p = 0.031), and a diagnosis of carcinoma of the pancreas (p = 0.027). When a clinically significant POPF rate was analysed based on the pancreatic duct diameter, pancreatic duct size ≤ 1 mm had the highest POPF rate (35.7%). There was a significant difference in POPF rate between adjacent ductal diameter ≤ 1 mm and > 1 mm to 2 mm (35.7% vs 13.3%; p = 0.040). Multivariable analysis showed that for the soft pancreas, pancreatic duct diameter ≤ 1 mm was the only significant predictive factor for POPF (p = 0.027).
Conclusions: DTMPJ can be safely performed for pancreatic duct > 1 mm without significantly increased POPF risk.
Keywords : Pancreaticoduodenectomy; Pancreaticojejunostomy; Pancreatic fistula

 

November 2021, 25 (4)